TV Doctor Travels Hundreds of Miles for Hip Replacement

Popular television doctor and GP Dr Hilary Jones has spoken out in praise of the NHS Patient Choice system after travelling almost 180 miles from his Kent home for a second hip replacement, a decision he says helped him fast-track his care and avoid months of waiting.

The 72-year-old, best known for his frequent health commentary on British television, underwent the procedure at Practice Plus Group’s new hospital in Birmingham, making a 360-mile round trip to benefit from shorter waiting times. “I’d do it again in a heartbeat for faster, quality care,” said Dr Hilary. “Patient Choice gives people real power, they just need to know it’s there.”

His decision to travel so far was made possible by NHS Patient Choice, a system that grants patients a legal right to choose where they receive NHS treatment. Many do not realise that this includes private hospitals which accept NHS patients, provided that the cost to the NHS is the same. For Dr Hilary, the result was a significantly shorter wait, with the added reassurance of high-quality care in a brand-new facility.

“It was over 180 miles from my home to Birmingham, but as it’s a new hospital and it’s a private hospital that treats NHS patients, they could get me in very quickly just with a referral from my GP,” he said. “You can choose to be referred to a private hospital at the outset, or you can switch hospitals like I did if you’re facing delays locally. It’s free for the patient and costs the NHS no more than if that same patient had their op at an NHS hospital.”

His experience is part of a wider discussion about how patients in England can and should be made more aware of their legal right to choose. The Patient Choice scheme has existed for years but is frequently underutilised, often because people do not know it exists or assume it involves additional cost. Yet, as Dr Hilary emphasised, “For people like me, who are lucky enough to be mobile despite needing an operation, it makes complete sense to find a hospital that can do your operation sooner so you can get on the road to recovery sooner.”

“I am delighted with the result so far,” he added. “Every single person that looked after me was amazing and couldn’t have done any more.”

A new survey of 1,000 adults living with chronic aches and pains, including those in need of hip and knee replacements, suggests Dr Hilary’s decision to travel is one many people would be happy to mirror, if they knew they had the option.

The survey, commissioned by Practice Plus Group, revealed that the average patient would be prepared to travel 60 miles for surgery if it meant being treated within three to four weeks. For a six-to-eight-week timeframe, people were willing to go up to 49 miles and one in ten said they would travel over 200 miles if it meant having surgery within a month.

However, more than half of respondents, 55 per cent, were unaware that NHS Patient Choice could allow them to seek treatment at an alternative hospital with a shorter waiting list. In many cases, this could include private hospitals that have been commissioned by the NHS to treat its patients at no extra cost.

For those facing long delays, the motivations for travel were clear. Of those surveyed, 36 per cent were currently on an NHS waiting list, and 17 per cent had been waiting for more than a year. A majority (68 per cent) cited prolonged discomfort and pain as a key reason for wanting faster surgery, while 55 per cent said they simply wanted to return to their normal lives. For 63 per cent, avoiding the emotional stress of continued delays was also a factor.

Yet despite the existence of this system, 88 per cent of those surveyed believed the Patient Choice option needed to be promoted more widely, highlighting a major information gap between what is legally available and what most patients are aware of.

For those considering paying privately, cost remained a significant concern. A third of respondents said they would be willing to travel for more than 90 minutes if it meant saving at least £2,000 on the cost of a hip or knee replacement, suggesting that time and money remain closely linked in how patients make healthcare decisions.

Dr Hilary concluded by pointing to future changes that may make navigating the system easier. “The NHS App is going to be developed further to make this easier, and you can speak to your GP about your choices,” he said. “People don’t want to be on a waiting list. They want to get on with their lives.”

As more hospitals like Practice Plus Group’s Birmingham site come online, and awareness of patient choice continues to grow, the message is becoming clearer: if you’re prepared to travel, the NHS may be able to see you sooner, and the journey could be well worth it.

Originally published by the Greater Birmingham Chambers of Commerce at: https://www.greaterbirminghamchambers.com/resource/celebrity-doctor-travels-180-miles-for-fast-access-nhs-surgery-in-birmingham.html?utm_campaign=EMAIL_CLD_290725&utm_medium=email

Author

Leave A Comment

Shabna Raja

Advisory Partner,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Shabna Raja is a senior leader in enterprise transformation within Life Sciences, with over 20 years’ experience spanning pharma, consumer health and large-scale digital programmes.

She specialises in bridging strategy and execution – helping organisations translate AI, data and digital innovation into tangible business outcomes. Her work focuses on complex transformation
initiatives across commercial, data and operating model domains within regulated environments.

Shabna spent seven years at GSK, where she played a key role in transformation programmes, including as part of the Consumer Health joint venture with Pfizer — one of the most significant integrations in the sector. This experience provided her with deep expertise in  organisational change, integration and operating model evolution at global scale.

More recently, she has spent over three years working closely with Haleon through a strategic
services partnership, leading enterprise client engagement and managing a multi-million-pound account while supporting transformation across a newly independent global organisation.

Her experience spans the end-to-end life sciences value chain, including R&D, commercial, supply chain and patient engagement, giving her a holistic perspective on how technology and transformation can unlock value across the industry.

Amjad Khan

Executive Partner,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Amjad Khan is a UK-based entrepreneur, AI strategist, and senior technology leader with over 15 years of experience at Pfizer, where he held multiple leadership roles across digital strategy and transformation. As Global Digital Client Partner, he was responsible for digital strategy and execution across Global Business Units covering Vaccines, Hospital, and Medical Affairs. Most notably, he led the commercial launch for the Covid franchise transforming and accelerating the model for how new medicines are brought to market.

Following his tenure at Pfizer, Amjad channelled his expertise into building at the frontier of AI. His work spans AI leadership, stakeholder engagement, and agile delivery helping organisations adopt
and scale emerging  technologies to drive meaningful outcomes.

Dr. Richard Fallon | Business Consultant | WM Life Sciences

Dr. Richard Fallon

Co Founder, Life Sciences Week 
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Dr Richard Fallon is an entrepreneur and ecosystem builder who connects industry leaders, investors and public-sector stakeholders to accelerate collaboration and commercial growth.

As the Founder of the Technology Supply Chain and co-founder of the Innovation Awards, he has spent more than two decades convening influential networks that help emerging businesses find capital, strategic partners and new routes to market.

Richard’s work spans leadership and consultancy across major organisations, alongside building membership and partnership platforms that bring universities, industry and investors into the same room – and turn conversations into practical outcomes.

With his focus on life sciences, Richard supports organisations and people driving breakthroughs in healthcare, biotechnology, medical technology and advanced research. He is passionate about creating the conditions for transformative ideas to move from concept to real-world impact – by connecting innovators with the funding, expertise and opportunities they need to scale.

Through Life Sciences Week, Richard is championing the UK’s world-class life sciences community and helping position it at the forefront of innovation, investment and patient outcomes.

Paul Cadman | Executive Chairman | WM Life Sciences

Prof Paul Cadman

CEO of One Thousand Trades Group & Co-founder of Life Sciences Week,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Prof. Paul Cadman is a nationally and internationally recognised, award-winning inclusive leader and “knowledge broker”, known for bringing people, ideas and organisations together to turn ambition into deliverable outcomes.

His experience spans Research, Technology, Manufacturing, Consultancy and Membership Organisations – giving him a rare ability to translate between sectors, priorities and professional cultures in a way that builds trust and unlocks progress.

Across his career, Paul has helped take concepts from inception through to scale, including initiatives that have generated £100m+ in turnover. He combines strategic thinking with an extensive network, supporting organisations to drive organic growth, forge partnerships and deliver meaningful business transformation. He is particularly valued for his ability to connect the right stakeholders at the right time, and create the conditions for collaboration to become action.

Through Life Sciences Week, Paul helps convene the communities shaping innovation – bringing together research, industry and investment to strengthen relationships, spotlight opportunity, and accelerate real-world impact.

Amy Deakin | Chief of Staff | WM Life Sciences

Amy Deakin

Event Managing Director,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Amy Deakin is a Birmingham-based leader specialising in building partnerships and fostering innovation in the life sciences sector. With a degree in Sport and Exercise Science, Amy brings a grounded understanding of human health and performance to her work and a strong interest in the developments shaping healthcare today.

Amy is Managing Director of Life Sciences Week, part of the One Thousand Trades Group, and also serves as Director of One Thousand Trades Events. In these roles, she convenes researchers, clinicians and industry leaders to strengthen collaboration, unlock new partnerships and help accelerate real-world innovation across the life sciences ecosystem.

Her career spans both commercial and third-sector environments. She began in automotive design, delivering projects for Volkswagen, McLaren, Bentley and Jaguar Land Rover, before moving into the third sector with Acorns Children’s Hospice. She later joined Western Union, working as a Partnerships Manager for international payments

An avid netballer, Amy is a committed advocate for health and wellbeing – bringing energy, clarity and connection to everything she builds, and actively involved as a participant in health related research studies.

    Award Category Voting

    Here's a list of all categories you can vote for. Simply click each category to cast your vote. Voting in each category is not mandatory, so please feel free to click just the category that interests you.

    Day you've not voted in, will be denoted with an ❌

    If you're having issues submitting the form, please ensure all the category boxes are closed and try again.

    Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

    No VoteProf. Alex RichterBlack Space TechnologyAston Vision Sciences

    Celebrating an emerging leader making significant contributions to the field through research, innovation, or leadership.

    Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

    No VoteShashank Chaganty – VichagLeah Vanono - PBS InnovationsKloe Avon- KZ Organics

    Honouring successful cross-sector partnerships driving advancements in life sciences, from academia to industry.

    No VoteProf Liam Grover- WMHTIAJudith Stewart- Health Innovation West MidlandsAdam McGuinness - Plug and Play

    Awarding an individual or organisation for exceptional long-term impact on the industry.

    No VoteDavid KidneyMedilink MidlandsUniversity of Birmingham

    Highlighting innovations in treatments, diagnostics, or healthcare delivery that have significantly improved patient outcomes.

    No VoteJean-Louis Duprey - Linear DiagnosticsSian Dunning - MD-TECKarim Vissangy - HoloMedix

    Your Details